Tenderwize
Wróć do wyszukiwania

Pharmaceutical Products

Amgros I/S·København Ø, Denmark·DKK 1564M | EUR 209.2M·Deadline Sep 03, 2026 · 11 days left·Open·Supplies
High valueStructured notice only
Oryginalny tytuł ogłoszenia

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

80/100

Ocena szansy

PromisingLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

80 / 100

Złożoność

30 / 100

Czynniki ryzyka

The stated estimated quantities are indicative only. Actual demand may be lower or higher based on patient needs and tr...

The framework is non-exclusive and without purchase obligation. The buyer may purchase from other sources even if you w...

Submission deadline in 11 days

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Strong opportunity

Kluczowe fakty

  • DKK 1564M estimated value
  • Supplies contract
  • 2 lots
  • Duration until Dec 2028
  • Supply of Daratumumab (ATC L01FC01) in two different formulations and strengths.
  • Lot 1: 1800 mg injection, estimated 610,073 units.
Pokaż pełne podsumowanie

This is an open tender (framework agreement) by Amgros I/S for the supply of pharmaceutical products (Daratumumab) to Danish public hospital pharmacies. The tender is divided into two separate lots, each representing a different product form/dosage. Award is based solely on price (100% weight). No minimum eligibility requirements are imposed. The total estimated framework value is DKK 1,564,000,000 (approx. EUR 208,873,981). The procurement is EU-funded and conducted under Directive 2014/24/EU. Submission is electronic via a portal, with a deadline of 2026-09-03. Important: no procurement documents were analyzed; all data comes from the structured notice and XML notice.

Ryzyka

The stated estimated quantities are indicative only. Actual demand may be lower or higher based on patient needs and tr...

The framework is non-exclusive and without purchase obligation. The buyer may purchase from other sources even if you w...

Submission deadline in 11 days

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Open procedure for a framework agreement.
  • Variants are not allowed.

Administrative

  • Tenders must be submitted electronically via Amgros procurement portal.

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

100% price – lowest price wins.100%

Lot 2

100% price – lowest price wins.100%

Zamawiający

Lokalizacja

København Ø, DNK

Profil zamawiającego

Otwórz profil

Identyfikator

14479880

Działalność

Health

Części (2)

LOT-0001

Tender No. 1

Supply of Daratumumab injection 1800 mg, estimated 610,073 units. Framework agreement with no purchase obligation. Real consumption may vary significantly from estimates.

SuppliesFrameworkEU fundedElectronic submission

EUR 209.2M

Szacowana wartość

Lokalizacja

DK011, Denmark

Czas trwania

Dec 2026 - Dec 2028

Kategoria

Pharmaceutical products

Kryteria udzielenia

Price

LOT-0002

Tender No. 2

Supply of Daratumumab infusion 20 mg/ml in two pack sizes (5 ml and 20 ml), combined estimated 712 units. Framework agreement with no purchase obligation. Real consumption may vary.

SuppliesFrameworkEU fundedElectronic submission

EUR 209.2M

Szacowana wartość

Lokalizacja

DK011, Denmark

Czas trwania

Dec 2026 - Dec 2028

Kategoria

Pharmaceutical products

Kryteria udzielenia

Price

Szczegóły zamówienia

Data publikacji
09 Jul 2026
Języki
Danish, Swedish

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
477000-2026

Dokumenty (1)

Podobne przetargi